Blinatumomab - Amgen
At a glance
- Drug Originator Micromet Inc
- Drug Licenced by BeiGene; Clinigen; Dr Reddys Laboratories
- Drug Class Antineoplastics; Bispecific antibodies; Immunotherapies
- Mechanism of Action Antibody-dependent cell cytotoxicity; T lymphocyte stimulants
- USA Patent Applicants AMGEN
- USA Patents 51
- BLAs 1
- International Patents 554
Disclaimer